|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Jounce Therapeutics (NASDAQ: JNCE) through any online brokerage.
The latest price target for Jounce Therapeutics (NASDAQ: JNCE) was reported by Piper Sandler on March 15, 2021. The analyst firm set a price target for 20.00 expecting JNCE to rise to within 12 months (a possible 185.71% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Jounce Therapeutics (NASDAQ: JNCE) is $7 last updated Today at 7:15:17 PM.
There are no upcoming dividends for Jounce Therapeutics.
There is no upcoming split for Jounce Therapeutics.
Jounce Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.